Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Illumina, Inc. - Common Stock
(NQ:
ILMN
)
141.07
-4.76 (-3.26%)
Official Closing Price
Updated: 4:15 PM EST, Jan 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Illumina, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
Why Illumina (ILMN) Shares Are Falling Today
July 09, 2025
Shares of genomics company Illumina (NASDAQ:ILMN) fell 4.2% in the morning session after a Citi analyst downgraded the stock to 'Sell' from 'Neutral' and lowered the price target.
Via
StockStory
Topics
Government
World Trade
Where Illumina Stands With Analysts
↗
July 08, 2025
Via
Benzinga
Illumina (ILMN) Stock Trades Down, Here Is Why
July 07, 2025
Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.6% in the afternoon session after the major indices pulled back (Nasdaq -0.8%, S&P 500 -0.77%), largely due to escalating concerns surrounding...
Via
StockStory
Topics
Artificial Intelligence
Government
Stocks
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
July 07, 2025
From
iRhythm
Via
GlobeNewswire
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
5 Must-Read Analyst Questions From Illumina’s Q1 Earnings Call
July 03, 2025
Illumina’s first quarter results reflected ongoing challenges in the global genomics market, as the company’s performance fell short of market expectations, prompting a negative reaction from...
Via
StockStory
Topics
Earnings
World Trade
“Mag 7 Undercard Movers: IBO, SNYR, CTOR, PNPN.V, LAB – Breakthroughs in Military Defense, Tech, Medical & Healthcare Fuel Market Buzz”
June 23, 2025
Via
AB Newswire
Topics
Artificial Intelligence
SomaLogic Acquisition Marks Next Step In Illumina's Advanced Biomarker Push
↗
June 23, 2025
Illumina will acquire SomaLogic to expand in proteomics, adding new revenue streams and accelerating tech development in multiomics.
Via
Benzinga
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Brush Off
June 20, 2025
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...
Via
StockStory
Topics
Energy
3 Reasons ILMN is Risky and 1 Stock to Buy Instead
June 18, 2025
What a brutal six months it’s been for Illumina. The stock has dropped 33.6% and now trades at $89.03, rattling many shareholders. This may have investors wondering how to approach the situation.
Via
StockStory
Retail Investors Flock To Incyte As Drug Data, Qiagen Deal Fuel Optimism
↗
June 16, 2025
Stifel also upgraded the stock to ‘Buy’ with a $107 price target.
Via
Stocktwits
Datadog To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
June 11, 2025
Via
Benzinga
Breaking Down Illumina: 11 Analysts Share Their Views
↗
June 11, 2025
Via
Benzinga
3 Mid-Cap Stocks Walking a Fine Line
June 11, 2025
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...
Via
StockStory
ILMN Q1 Earnings Call: Clinical Growth and Cost Actions Offset Research and China Headwinds
June 10, 2025
Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.4% year on year to $1.04 billion. Its non-GAAP profit of $0.97 per...
Via
StockStory
Topics
Economy
World Trade
Cathie Wood Sells Tesla Stock As Chinese Rivals Gain Ground — Ark Dumps Palantir Amid Privacy Concerns
↗
June 02, 2025
On Monday, Cathie Wood-led Ark Invest sold shares of Tesla and Palantir, amidst competition and data misuse concerns. Ark also made significant trades in other companies, such as eToro and Illumina.
Via
Benzinga
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit
↗
May 26, 2025
Cathie Wood underscored the application of AI in the healthcare sector by sharing new research by Mass General Brigham.
Via
Benzinga
Topics
Artificial Intelligence
Life Sciences Tools & Services Stocks Q1 Recap: Benchmarking Illumina (NASDAQ:ILMN)
May 25, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Danaher, Illumina, Globalstar, and Insperity Shares Plummet, What You Need To Know
May 21, 2025
A number of stocks fell in the afternoon session after the major indices fell further in the afternoon (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft...
Via
StockStory
Topics
Bonds
Stocks
What 15 Analyst Ratings Have To Say About Illumina
↗
May 20, 2025
Via
Benzinga
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal
↗
May 19, 2025
Regeneron (REGN) to acquire 23andMe for $256 million, plans to maintain consumer services and uphold privacy policies. Deal expected to close Q3 2025.
Via
Benzinga
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%
↗
May 16, 2025
Carl Icahn boosts holdings in Illumina and JetBlue, showing confidence in biotech and airlines. He also trims exposure to Southwest Gas Holdings.
Via
Benzinga
3 Volatile Stocks with Mounting Challenges
May 13, 2025
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
Via
StockStory
Illumina Analysts Lower Their Forecasts After Q1 Results
↗
May 12, 2025
Via
Benzinga
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
↗
May 12, 2025
Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space.
Via
Benzinga
Topics
Artificial Intelligence
10 Health Care Stocks With Whale Alerts In Today's Session
↗
May 09, 2025
Via
Benzinga
Illumina’s (NASDAQ:ILMN) Q1 Sales Top Estimates
May 08, 2025
Genomics company Illumina (NASDAQ:ILMN) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 1.4% year on year to $1.04 billion. Its non-GAAP profit of $0.97 per share...
Via
StockStory
Earnings To Watch: Illumina (ILMN) Reports Q1 Results Tomorrow
May 06, 2025
Genomics company Illumina (NASDAQ:ILMN) will be announcing earnings results this Thursday afternoon. Here’s what to expect.
Via
StockStory
Assessing Illumina: Insights From 16 Financial Analysts
↗
April 29, 2025
Via
Benzinga
Rep. Thomas Kean Has Bought Up to $45K Worth Of Illumina Stock: Here's What You Should Know
↗
April 21, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today